CLINICAL_TRIALS
research
· 2025-11-21
Clinical Trial Update: Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication [Phase 2, Phase 3]
Summary
A head-to-head Phase 2/3 clinical trial comparing tegoprazan 50 mg twice daily plus amoxicillin 1 g three times daily with vonoprazan 20 mg twice daily plus amo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: First People's Hospital of Hangzhou | Conditions: Helicobacter Pylori Infection | Phase 2, Phase 3 | Status: RECRUITING